Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|ADVL1514||COG||A Phase 1 Study of ABI-009 (nab-Rapamycin) (IND# 133537) in Pediatric Patients with Recurrent or Refractory Solid Tumors, Including CNS Tumors as a Single Agent and in Combination with Temozolomide and Irinotecan||Pediatric CIRB||Available to Open|
|9824||ETCTN||A Phase 1 Study of alisertib (MLN8237) in combination with mFOLFOX in gastrointestinal tumors||Adult CIRB - Early Phase Emphasis||Completed|
|9853||ETCTN||A Phase 1 Study of AZD1775 in Combination with Belinostat in Relapsed and Refractory Myeloid Malignancies and Selected Untreated Patients with Acute Myeloid Leukemia||Adult CIRB - Early Phase Emphasis||Available to Open|
|10131||ETCTN||A Phase 1 Study of AZD8186 in Combination with Docetaxel in patients with PTEN mutated or PIK3CB mutated advanced solid tumors, potentially amenable to docetaxel||Adult CIRB - Early Phase Emphasis||Available to Open|
|10030||ETCTN||A phase 1 study of blinatumomab in combination with checkpoint inhibitor(s) of PD-1 (nivolumab) or both PD-1 (nivolumab) and CTLA-4 (ipilimumab) in patients with poor-risk; relapsed or refractory CD19+ precursor B-lymphoblastic leukemia||Adult CIRB - Early Phase Emphasis||Available to Open|
|9681||ETCTN||A Phase 1 Study of Cabozantinib plus Nivolumab (CaboNivo) Alone or in Combination with Ipilimumab (CaboNivoIpi) in Patients with Advanced/Metastatic Urothelial Carcinoma and other Genitourinary Tumors.||Adult CIRB - Early Phase Emphasis||Available to Open|
|10399||ETCTN||A Phase 1 Study of Entinostat in Combination with Atezolizumab / Carboplatin / Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer||Adult CIRB - Early Phase Emphasis||Available to Open|
|ADVL1513||COG||A Phase 1 Study of Entinostat; An Oral Histone Deacetylase Inhibitor; In Pediatric Patients with Recurrent or Refractory Solid Tumors; Including CNS Tumors and Lymphoma||Pediatric CIRB||Available to Open|
|ADVL1314||COG||A Phase 1 Study of Eribulin Mesylate (E7389; IND #116;292); A Novel Microtubule Targeting Chemotherapeutic Agent in Children with Refractory or Recurrent Solid Tumors (Excluding CNS); Including Lymphomas: A Participation Limited to the COG Phase 1 Consortium||Pediatric CIRB||Completed|
|10410||ETCTN||A Phase 1 Study of IPdR in Combination with Capecitabine and Radiotherapy in Rectal Cancer||Adult CIRB - Early Phase Emphasis||Available to Open|